Oncothyreon to Present at Cowen and Company 33rd Annual Health Care Conference
SEATTLE, WA, Feb. 27, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman , M.D., President and Chief Executive Officer, will present at the Cowen and Company 33rd Annual Health Care Conference in Boston on Wednesday, March 6, 2013 at 8 a.m. Eastern.
A live and archived webcast of the presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.
About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development
of innovative therapeutic products for the treatment of cancer.
Oncothyreon's goal is to develop and commercialize novel synthetic
vaccines and targeted small molecules that have the potential to
improve the lives and outcomes of cancer patients. For more
information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.
More by this Source
Oncothyreon Announces Data for L-BLP25 and PX-866 to be Presented at American Society of Clinical Oncology Meeting
May 16, 2013, 06:00 ET
Oncothyreon Reports First Quarter 2013 Financial Results
May 09, 2013, 16:05 ET
Oncothyreon Announces First Quarter 2013 Financial Results Conference Call
May 02, 2013, 08:00 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.